News Sentiment

BALAXI sentiment intelligence

Balaxi Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 17 relevant articles
Exchange NSI India
Sector Healthcare Market context
Industry Drug Manufacturers - Specialty & Generic Read-through group
Latest close 24.17 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

86/100 classification confidence.

Company focus 17

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

+2.1% over one week, +5.8% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Balaxi Pharmaceuticals (BALAXI) Q3 2025 earnings summary

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 86/100 classification
One-week reaction 2.1% Price confirming higher
Trend fit Trend inactive 5.8% over four weeks
Fair value -65.5% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 16
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 17
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
scanx.trade 2
simplywall.st 2
Indian Pharma Post 2
Quartr 1
ad-hoc-news.de 1
CNBC TV18 1
Moneycontrol.com 1
Business Standard 1

Event Lens

What the news is about

Classified themes
Market update 13
Earnings 2
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-17 of 17